Evidence map›Paper›PMID 30501676›Full record

ArticleEpidemiology and infection2018

Travel-associated Legionnaires' disease: would changing cluster definition lead to the prevention of a larger number of cases?

M C Rota, A Bella, M G Caporali, A Nicolau, V Drasar, M L Ricci, M Scaturro, M Gumá, S Crespi

Abstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Infection and drug resistance · 2026
    Review
  3. Article
  4. Review
  5. Occurrence ofPathogens (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M C RotaDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.ORCID https://orcid.org/0000-0002-9861-446X
A BellaDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
M G CaporaliDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
A NicolauConselleria de Salut i Consum, Palma de Mallorca, Spain.
V DrasarPublic Health Institute Ostrava, Vyskov, Czech Republic.
M L RicciDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
M ScaturroDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
M GumáConselleria de Salut i Consum, Palma de Mallorca, Spain.
S CrespiBiolinea Int., Palma de Mallorca, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to European Guidelines for Legionnaires' Disease prevention and control, travel-associated Legionnaires' disease (TALD) cases are managed differently if classified as sporadic or as part of a cluster and more stringent control measures are deployed after clusters are identified. In this study, we propose to modify the current cluster definition: 'two or more cases of Legionnaires' disease (LD) who stayed at, or visited, the same commercial accommodation site 2-10 days before onset of illness and whose onset is within the same 2-year period' with a new cluster definition, i.e. accommodation sites associated with multiple cases regardless of the time elapsed between them. TALD cases occurred in Italy and in the Balearic Islands between 2005 and 2015 were analysed applying the current European Legionnaires' Disease Surveillance Network (ELDSNet) cluster definition. In a sample of selected accommodation sites with multiple cases, a microbiological study was also conducted. Using the new definition, 63 additional sites (16.4% increase) and 225 additional linked cases (19.5% increase) were identified. Legionella pneumophila sg1 was isolated from 90.7% of the selected accommodation sites. The use of the here proposed TALD cluster definition would warrant a full investigation for each new identified case. This approach should therefore increase the number of sites that will require a risk assessment and, in the presence of an increased risk, the adoption of LD control measures to hopefully prevent additional cases.

Indexed as

Accommodation siteLegionnaires' disease clusterTALD

Identifiers

PMID30501676
PMCPMC6518564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.